Effects of IL-1β Inhibition on Anemia and Clonal Hematopoiesis in the Randomized CANTOS Trial

Proteogenomic analyses aimed to understand the clinical response to canakinumab and underlying proteomic profiles in the context of clonal hematopoiesis and anemia.
[Blood Advances]

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News